E2F3 and neuroblastoma: Gain or amplification of chromosome 6p22.3 is not recurrent in NB [2,4,38], and E2F3 gene expression is not activated bona fide through chromosomal abnormalities, therefore an oncogenic mechanism probably exists that operates independently of gene amplification.